October 22, 2010
For Immediate Release
Baycrest’s virtual brain project receives $6.3M from American foundation
Toronto, Canada – The U.S.-based James S. McDonnell Foundation has awarded $6.3 million in new funding over the next three years to an international project led by Baycrest to create the world’s first functional, virtual brain.
Dr. Randy McIntosh, project leader.
Dr. Randy McIntosh talks about the virtual brain project (video) >
The project puts Canada in a global race to pull off a neuroscience feat that is comparable to decoding the human genome. The new funding is in addition to $7.5 million the prestigious American foundation provided five years ago to help launch the massive endeavour.
“On behalf of Baycrest and our international science team, we are energized by the continuing support and investment from the James S. McDonnell Foundation, who champion transformative research efforts,” said Dr. Randy McIntosh, project leader, senior scientist and vice-president of Research at Baycrest.
“The new funding helps our project move into its second phase and a step closer to creating a predictive modeling tool that will change the way we assess and rehabilitate brains that have suffered damage from stroke, epilepsy, or the early stages of Alzheimer’s.”
Susan Fitzpatrick, vice-president of the James S. McDonnell Foundation said “the Foundation is pleased to be able to contribute to this effort to bring cognitive neuroscience, computational biology, and clinical neurology together in an ambitious attempt to improve our abilities to alter the course of recovery for individuals with brain injuries.”
The project presents a massive informatics challenge that requires a team of scientists from Canada, the U.S., Europe and Australia to upload thousands of patterns of brain imaging data from healthy individuals and patient groups into several large super computers. Once that work is complete, the virtual brain will deliver the same observable measurements or functioning patterns as a real brain.
The implications of this new tool for clinical interventions will be revolutionary. A clinician will be able to upload brain imaging data from their patient’s unique neural architecture after a stroke, for example, into the synthetic healthy brain model to see how it responds to the disruption of normal network patterns and attempts to re-stabilize. This will assist the clinician in determining the treatment interventions that will likely have the best outcomes for their patient.
In addition to the James S. McDonnell Foundation, the Ontario Innovation Trust and Rx&D (Canada's Research-Based Pharmaceutical Companies) are supporting the project.
25.10.10
22.10.10
MED-IQ Organizers of CONTINUED MEDICAL EDUCATION
Programs are developed in full compliance with ACCME, OIG, and PhRMA guidelines and we guarantee every program is fair, balanced, independent, and free of commercial bias.
Team Med-IQ
Clinical content team develops programming from a participant perspective. Led by William Mencia, MD, and Rachel Karcher, PharmD, the Med-IQ team has more than 55 years of continuing medical education experience and also includes the clinical expertise of Sara Miller, MS, Allison Gardner, PhD, and Jean Cornish, RPh.
Med-IQ
5523 Research Park Drive
Suite 210
Baltimore, MD 21228
Phone: 866 858 7434
Fax: 866 419 5789
E-mail: info@med-iq.com
Team Med-IQ
Clinical content team develops programming from a participant perspective. Led by William Mencia, MD, and Rachel Karcher, PharmD, the Med-IQ team has more than 55 years of continuing medical education experience and also includes the clinical expertise of Sara Miller, MS, Allison Gardner, PhD, and Jean Cornish, RPh.
Med-IQ
5523 Research Park Drive
Suite 210
Baltimore, MD 21228
Phone: 866 858 7434
Fax: 866 419 5789
E-mail: info@med-iq.com
19.10.10
LOCKMED Medical Product Co. (Aluminium pharmaceutical container)
LOCKMED Medium Combination Lockbox
$20.99 (USA dollars)
LOCKMED SMALL Combination Lockbox
$18.99
LOCKMED LARGE KEY (not combination) Lockbox
$22.99
LOCKMED Medical Product Company
P.O. Box 13166
Pittsburgh, PA 15243
www.lockmed.com
Phone: (888) 458-2746
Email: info@lockmed.com
Carrying handle. WHITE CROSS on RED BACKGROUND DISK. Numbered RETURN FOR REWARD attached plastic label with details to contact TrackItBack service. www.TrackItBack.com.
(Canadian agent: wellbeings www.wellbeings.ca )
$20.99 (USA dollars)
LOCKMED SMALL Combination Lockbox
$18.99
LOCKMED LARGE KEY (not combination) Lockbox
$22.99
LOCKMED Medical Product Company
P.O. Box 13166
Pittsburgh, PA 15243
www.lockmed.com
Phone: (888) 458-2746
Email: info@lockmed.com
Carrying handle. WHITE CROSS on RED BACKGROUND DISK. Numbered RETURN FOR REWARD attached plastic label with details to contact TrackItBack service. www.TrackItBack.com.
(Canadian agent: wellbeings www.wellbeings.ca )
16.10.10
SARCOPENIC OBESITY
Sarcopoenic obesity discussed by Dr. William EVANS,PhD of GlaxoSmithKline,USA at Toronto meeting of American Society for Bone and Mineral Research.
Weight gain in elderly is 100% FAT: weight loss in elderly is 50% MUSCLE mass.
10 days in bed leads to 2K. muscle mass loss.
1% a year muscle mass lost after age 20.
Ann N Y Acad Sci. 2000 May;904:437-48.
Body composition in healthy aging.
Baumgartner RN.
Division of Epidemiology and Preventive Medicine, University of New Mexico School of Medicine, Albuquerque 87131, USA. rbaumgartner@salud.unm.edu
Abstract
Health risks in elderly people cannot be evaluated simply in conventional terms of body fatness or fat distribution. Elderly people have less muscle and bone mass, expanded extracellular fluid volumes, and reduced body cell mass compared to younger adults. These nonfat components of body composition play critical roles, influencing cognitive and physical functional status, nutritional and endocrine status, quality of life, and comorbidity in elderly people. Different patterns of "disordered body composition" have different relationships to these outcomes and may require different, tailored approaches to treatment that combine various exercise regimens and dietary supplements with hormone replacement or appetite-stimulating drugs. Skeletal muscle atrophy, or "sarcopenia," is highly prevalent in the elderly population, increases with age, and is strongly associated with disability, independent of morbidity. Elders at greatest risk are those who are simultaneously sarcopenic and obese. The accurate identification of sarcopenic obesity requires precise methods of simultaneously measuring fat and lean components, such as dual-energy X-ray absorptiometry.
Weight gain in elderly is 100% FAT: weight loss in elderly is 50% MUSCLE mass.
10 days in bed leads to 2K. muscle mass loss.
1% a year muscle mass lost after age 20.
Ann N Y Acad Sci. 2000 May;904:437-48.
Body composition in healthy aging.
Baumgartner RN.
Division of Epidemiology and Preventive Medicine, University of New Mexico School of Medicine, Albuquerque 87131, USA. rbaumgartner@salud.unm.edu
Abstract
Health risks in elderly people cannot be evaluated simply in conventional terms of body fatness or fat distribution. Elderly people have less muscle and bone mass, expanded extracellular fluid volumes, and reduced body cell mass compared to younger adults. These nonfat components of body composition play critical roles, influencing cognitive and physical functional status, nutritional and endocrine status, quality of life, and comorbidity in elderly people. Different patterns of "disordered body composition" have different relationships to these outcomes and may require different, tailored approaches to treatment that combine various exercise regimens and dietary supplements with hormone replacement or appetite-stimulating drugs. Skeletal muscle atrophy, or "sarcopenia," is highly prevalent in the elderly population, increases with age, and is strongly associated with disability, independent of morbidity. Elders at greatest risk are those who are simultaneously sarcopenic and obese. The accurate identification of sarcopenic obesity requires precise methods of simultaneously measuring fat and lean components, such as dual-energy X-ray absorptiometry.
5.10.10
FOLLICULAR UNIT EXTRACTOR for HAIR TRANSPLANTATION
FUE : Follicular Unit Extractor invented by PARIS, Plastic Surgeon PASCAL BOUDJEMA
69 rue de la Tour.
docteur@pascal-boudjema.com
(FUEPK-7000)new model $8,000 from www.bkworldco.com South Korea.
69 rue de la Tour.
docteur@pascal-boudjema.com
(FUEPK-7000)new model $8,000 from www.bkworldco.com South Korea.
4.10.10
SYNOVIS LIFE TECHNOLOGIES,Inc of St.Paul, MN.
SYNOVIS SURGICAL INNOVATIONS (a division of Synovis Life Technologies), synovissurgical.com, presented a conference on the VERITAS COLLAGEN MATRIX,(bovine pericardial xenograft), at the Toronto meeting of the American Association of Plastic Surgeons. Speakers were Michael MEININGER,Beaumont Hospital,Mich.; Mark MOFID,Univ.Calif.,San Diego; Daniel MOORADIAN PhD,Synovis Life Tech.; Donald MORRIS, Harvard Med.School; Martin NEWMAN, Cleveland Clinic, Weston,Fl. Main uses of VERITAS COLLAGEN MATRIX are BREAST RECONSTRUCTION & VENTRAL HERNIA REPAIR. Cost of a large sheet for Ventral repair can be $3,000.
SYNOVIS LIFE TECHNOLOGIES (NASDAQ:SYNO) Shares increased approx 800% since 1985.
SYNOVIS LIFE TECHNOLOGIES (NASDAQ:SYNO) Shares increased approx 800% since 1985.
Subscribe to:
Posts (Atom)